World Health Organization site
Skip Navigation Links

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Last refreshed on: 19 February 2015
Main ID:  NCT00004807
Date of registration: 24/02/2000
Prospective Registration: No
Primary sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Public title: Study of the Pathogenesis of Rett Syndrome
Scientific title:
Date of first enrolment: January 1995
Target sample size: 120
Recruitment status: Completed
Study type:  Interventional
Study design:  Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Name:     Sakkubai Naidu
Affiliation:  Johns Hopkins University
Key inclusion & exclusion criteria


Rett syndrome

Diagnosis confirmed on study

Age minimum: N/A
Age maximum: 45 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Rett Syndrome
Drug: dextromethorphan
Drug: Donepezil
Drug: topiramate
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Johns Hopkins University
Ethics review
Results available:
Date Posted:
Date Completed:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history